Richard Sharpee
VP Technical Operations
Professional Overview
Richard Sharpee is an accomplished technical operations executive with over 20 years of experience in the pharmaceutical industry. As the VP of Technical Operations at Enzymatic Therapy Inc., he oversees all aspects of the company's manufacturing, engineering, and supply chain operations, driving innovation and efficiency to support the organization's growth and product development initiatives.
Experience Summary
Current Role
As the VP of Technical Operations at Enzymatic Therapy Inc., Richard is responsible for leading the company's technical operations, including manufacturing, engineering, and supply chain management. Under his leadership, the organization has consistently met or exceeded production targets, optimized operational processes, and maintained a strong focus on quality and compliance. Richard's strategic insights and hands-on approach have been instrumental in ensuring the company's ability to rapidly scale and respond to evolving market demands.
Career Progression
Prior to joining Enzymatic Therapy Inc., Richard held the position of Director of Pharmaceutical R&D at Abbott Labs, where he played a key role in developing and commercializing several successful drug products. During his tenure, he demonstrated a strong track record of driving operational excellence, implementing cost-saving initiatives, and fostering cross-functional collaboration to deliver innovative solutions.
Academic Background
Richard holds a Bachelor of Science degree in Chemical Engineering from the University of Wisconsin-Madison, where he graduated with honors. He is also a Certified Six Sigma Black Belt, reflecting his expertise in process improvement and optimization.
Areas of Expertise
- Pharmaceutical manufacturing and engineering
- Supply chain optimization and logistics management
- Quality assurance and regulatory compliance
- Process development and implementation
- Cross-functional team leadership and collaboration
- Strategic planning and business operations
Professional Impact
Throughout his career, Richard has made significant contributions to the pharmaceutical industry. At Enzymatic Therapy Inc., he has led the successful implementation of several high-impact initiatives, including the deployment of a state-of-the-art Enterprise Resource Planning (ERP) system, the optimization of the company's supply chain network, and the development of a robust quality management system that has resulted in a reduction in product recalls and regulatory citations.
Conclusion
With his extensive technical expertise, strategic vision, and proven track record of driving operational excellence, Richard Sharpee is a valuable asset to Enzymatic Therapy Inc. and the broader pharmaceutical industry. As the company continues to expand its product portfolio and reach new markets, Richard's leadership and innovative approach will be instrumental in ensuring the organization's continued success.
